Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
My order to sell half my shares at double the purchase price cleared while I was away from my desk. I now am playing on free shares and whatever I am able to sell them for is profit. EPRA is a winner for me. My next sell price is .75
GLTA
Vlad
GO EPRA
Bo Linton, President of GDT TEK, Inc., Will Discuss Planned Meeting With JV Partner in London Next Week and Provide Other Update
http://ih.advfn.com/p.php?pid=nmona&article=48074771&symbol=GDTK
GLTA
Vlad
GO GDTK
Barcharts is automated chart evaluation. It does not evaluate any fundamentals. What I have heard from chartists is that it is not too good at the chart either.
GLTA
Vlad
GO PHAR
Yes indeed there is very much a reason to respond to risk, that is how he gets paid and if all of you would stop talking to him he would get paid a whole lot less.
GLTA
Vlad
GO SNEY
These are the plans as they appear in the
INITIAL COMPANY INFORMATION AND DISCLOSURE STATEMENT
filed Apr 13, 2011, as you will notice today's PR affirms that Howard has a plan, reasons for it, and is following it. For those who have done their basic DD and have read the company's filings there is no surprise in the PR.
http://www.otcmarkets.com/otciq/ajax/showFinancialReportById.pdf?id=47788
Item XVI Management’s Discussion and Analysis or Plan of Operation.
A. Plan of Operation
Market conditions favoring the new field of Pain Management are now assuming an expansive
dimension of therapeutic and commercial opportunity, and PharmStar’s AQUAPRIN is primed
to assume a position of market leadership. It is especially noted that other major analgesic
products are introducing liquid versions of their pain relievers. Liquid versions are beginning
to take hold, which is especially good for AQUAPRIN, since it is in liquid form, although
much more effective and competitive. Indeed, AQUAPRIN, uniquely fast acting and safer to
the stomach, exhibits many important pharmacological, and commercial advantages over all
other aspirin products including, especially, aspirin itself. Rapid market penetration is
expected owing to AQUAPRIN ’s unique selling proposition. AQUAPRIN is also superior in
effectiveness than any other OTC pain reliever. In the US, no oral competing products exist, in
terms of potency, rapid onset of action, and gastric tolerance. Neither does any competing
product exists that can deliver a comparably high percentage of un-degraded salicylates per
analgesic or cardio protective dose.
1. It will, for this reason, be strategically launched in such target sectors as AARP,
hospitals and nursing home pharmacies, and by direct marketing, with detail samples
and technical data, to medical professionals, as well as via special “2-for-1” buying
incentives for distributors. Internet banners, infomercials, and consumer hot-lines will
likewise be deployed after the initial 6 months, as will dedicated e-commerce,
permitting direct purchase of AQUAPRIN from the Company. A special information
and product campaign will be aimed toward emergency medical service organizations.
2. The Company recognizes the difficulty for a new product to secure prominent shelf
space in drugstores. Its strategy will, therefore, depend on vigorous sales promotion and
highly visible point-of-purchase displays at high-traffic consumer corridors. The
company feels that the product is so superior to all other OTC pain relievers, that once
tried with free samples, the public will demand the product. Also, local-media coupons
and direct marketing will be creatively deployed by the Company to get its products
distributed. The Company will also attempt to make a strategic alliance with a major
pharmaceutical manufacturer and/or a pharmaceutical distribution company.
3. The Company’s strategic marketing plan includes English/Spanish promotional,
packaging and medicinal insert formats. Overall Hispanic growth demographics show
manifold increases in every quadrant of this population sector over the past 3 decades.
AQUAPRIN’s bilingual debut also translates into easier brand-recognition and
penetration of Mexican, Central and South American markets as soon as practicable,
and without having to revamp or redesign product packaging or advertising.
4. Once The Company’s brand name is established in the market, the public is expected to
express its awareness of AQUAPRIN’ s benefits by seeking out and purchasing the
product on its own initiative. Since there exists no alternative sodium-free soluble
analgesic product, AQUAPRIN should enjoy a market dominance.
5. A prescription dose form will be marketed through doctors.
19
Corporate Funding and Direction
Phase One
Raise $2,800.000 million dollars, which will accomplish the following:
Use of Proceeds (Phase One)
1. Complete construction of R&D laboratory and Pilot production facilities.
2. Provide laboratory and pilot production equipment.
3. Scale up to pilot production capacity.
4. Register Facility and products with the FDA
5. Validate processes & equipment.
6. Do 90 day stabilities to get 2 year dating.
7. Write “Standard Operating Procedures”.
8. Expand laboratory area to be able to develop follow on products and line extensions.
9. Establish the manufacture, marketing, and sale of AQUAPRIN in limited quantities with
phase 1 funding. Thoroughly engage its professional marketing team to get AQUAPRIN
into distribution channels and in to drugstore shelves, hospitals, nursing homes, and into the
prescription drug markets and or make licensing and distribution agreements as soon as
possible.
10. Continue to develop advanced formulations, improvements and line extensions
11. Complete development of the Insta-Prin Emergency administration technology.
12. Develop several line extension of AQUAPRIN , such as: AQUAPRIN Cough & Cold,
AQUAPRIN Cold & Flu, AQUAPRIN Menstrual Pain. AQUAPRIN Migraine Pain.
13. Conduct clinical claim trials to make specific claims for the product.
Phase Two
Raise $3,600.000 million dollars, which will accomplish the following:
Use of Proceeds (Phase Two)
· Initiate full scale clinical studies in order to meet FDA and FTC requirements to make claims
of “fastest acting, Safest, and most effective” analgesic on the market.
• Make leasehold improvements to a physical plant.
• Establish full-scale production capability with phase 2 funding.
• Continue to develop advanced formulations, improvements and line extensions.
• Thoroughly engage its professional marketing team to get AQUAPRIN into retail
distribution channels and in to drugstore shelves, hospitals, nursing homes, and into the
prescription markets and or make licensing and distribution agreements as soon as possible.
• Complete development of the Insta-Prin emergency administration technology.
• Develop several line extension of AQUAPRIN, such as: AQUAPRIN Cough & Cold,
AQUAPRIN Cold & Flu, AQUAPRIN Menstrual Pain, AQUAPRIN Migraine Pain.
• License distribution for European and Asian markets.
GLTA
Vlad
GO PHAR
It is highly doubtful that this product is safe. It may be safer than cigarettes but nicotine is a poison and could never be called safe.
GLTA
Vlad
GO SFIO
The ID is 0203125
The mine is listed as Abandoned which is why it did not show in the basic search.
Thanks for the link to MSHA
http://www.msha.gov/drs/drshome.htm
Current Mine Information
Mine ID: 0203125
Operator: Pine Creek Mining, Inc.
Operator History for Mine ID: 0203125
Operator Name Begin Date End Date
Pine Creek Mining, Inc. 7/12/2006
How do I use this information? Click Here
Opr. Begin Date: 7/12/2006
Mine Name: Gold Basin
Current Controller: Don L Jenkins
Controller Start Date: 7/12/2006
Mine Status: Abandoned
Status Date: 7/12/2006
Mined Material: Gold Ore
Type of Mine: Surface
Location: Yavapai County, AZ
Address of Record: 13197 SW Essex Drive
Tigard, OR 97223
GLTA
Vlad
GO WSRA
Western Sierra Confirms New Production Agreement for the Gold Basin Mine
http://ih.advfn.com/p.php?pid=nmona&article=47730759
Western Sierra Mining Corp. and Diversified Secure Ventures Corp. Open Formal Discussions
http://ih.advfn.com/p.php?pid=nmona&article=47902990&symbol=WSRA
Company Notes
Formerly=Seamless Corp. until 11-2009
Formerly=Seamless Wi-Fi, Inc. until 8-2008
Formerly=Alpha Wireless Broadband, Inc. until 6-05
http://www.otcmarkets.com/stock/GDTK/company-info
from 6-2005 to 8-2008 it was SMWF became GDTK 11-2009
GLTA
Vlad
GO GDTK
There are 12 million shares available in the system for electronic trading, the rest of the float is in certificate form and although legal to trade would have to be sent to the broker and registered with DCCT before the could be sold. Howard says the people holding these are not interested in selling at this time.
GLTA
Vlad
GO PHAR
We need 7000 buy at .0138 to move it up a little more
GLTA
Vlad
GO SNEY
mmmmm Having a hard time keeping accountants
I think the FS will be delayed.
GLTA
Vlad
GO SNEY
FINRA Short Sale Volume Reporting’s are deceiving.
What follows is not by me but an edited version of a commonly posted article. . GLTA Vlad GO FFGO
FINRA Short Sale Volume Reporting’s are deceiving.
Notice to Members memo dated 9/29/2009
http://www.finra.org/Industry/Regulation/Notices/2009/P120045
To maintain proper trade volume reporting accuracy, a trade with multiple legs in the trade would only be reported once in the volume reports. The example given would be.
Investor A is long 100 shares and wants to sell. They enter the order through their broker that is routed to a market maker. That market maker will go out and sell the stock into the market before they have bought the stock from you/your broker to close out their account. They do not take possession first as there is no guarantee they can sell the order into the market. By this Notice, the actual sale INTO the market is a short sale because the market maker sold the stock into the market BEFORE they had purchased the stock from you. It is a technicality since they know there position will be closed out minutes later when they go in and buy your shares. To avoid doubling up on trade volume and distorting the picture, only the sale into the market (consolidated tape) is recorded and not the second leg which was the sale transaction between seller and market maker.
So, this is why the short sale volume is high but also why the FTD’s and bi-Monthly short interest reports are not showing any indications of this volume. The short isn’t really a short it is the execution of a long sale by a market maker.
Looks that way in my L2
GLTA
Vlad
GO FFGO
If the dollar club wins I am going to be a millionaire. GO VARMIT'S DOLLAR CLUB
GLTA
Vlad
GO FFGO
Why is FFGO 100% short everyday? Because it is a pos that no MM would want to hold. So they get an order to buy and they sell short on it, then they cover the short by buying some of the billions for sale. If they bought first they might get caught holding if the buy order got canceled before they finished the transaction. They do not want tho hold any FFGO.
GLTA
Vlad
GO FFGO
Wow, this filing seems to say that the common stock will be valued at more than .25 a year from now. I got to say Howard is a believer.
GLTA
Vlad
GO PHAR
You are right, from their first PR it said
The first version was not stable enough to get FDA approval. It has to have a shelf life of at least 2 years and the first version did not. There are no guarantees that Howard will be successful this time either. But he has not given up. New patents pending on the new formulation. Currently under testing for stability.
GLTA
Vlad
GO PHAR
So you do not have any thing to show that there is dilution. You just have your general miss trust of pinks and nothing more. What do other pink CEOs have to do with Howard?
GLTA
Vlad
GO PHAR
What evidence do you have that the company is selling stock? I do not see any indications of the in the day's trading patterns. And even worse, Howard said they would not for at least six months. If they are then we can not trust Howard and had all better run for the hills. I am staying long because I do not think there is any dilution going on.
GLTA
Vlad
GO PHAR
mmmm. The Copperstone mine has been in production for some time, FFGO is concerned with the South Copperstone an undeveloped area south of the Copperstone.
GLTA
Vlad
GO FFGO
Yes it has been on all my posts.
No I just stole it because it explains so much of what we see on the boards. I think I got it from querty, who uses it in his sig.
GLTA
Vlad
GO PHAR
No you did not miss it. I feel that it is misunderstood and not useful. All this BS about the MMs shorting is bogus. We need to wait until a failure to deliver report comes out before we know if there are NSS. Until then I am not planning on posting the daily report.
Fails-to-Deliver Data
http://www.sec.gov/foia/docs/failsdata.htm
Key Points About Regulation SHO
http://www.sec.gov/spotlight/keyregshoissues.htm
I am waiting for first half of May's FTD report.
GLTA
Vlad
GO PHAR
Buy on rumor sell on news. SOP in stocks.
GLTA
Vlad
GO PHAR
Thanks everyone!!
I am afraid it is my plan to be the bad cop and remove all TOS violations. So lets work and play nice together even with our negative neighbors. Lets all make some money!!!!
GLTA
Vlad
GO PHAR
PL? I think it means Pink Limited Information
GLTA
Vlad
GO GDTK
I may have been confused about the percentage, just writing off the cuff from what I remembered.
GLTA
Vlad
GO PHAR
As I understand it: Howard bought the stock shell of Big Star Media. (Big Star Meidia became a private company) Then the stock shell Big Star Media changed its name to Pharmstar Pharmaceuticals Inc and bought 85% of Howard's private company Pharmstar Inc. Then as soon as possible changed its ticker to PHAR.
GLTA
Vlad
GO PHAR
Tuesday's shorts 40%
Date|Symbol|ShortVolume|ShortExemptVolume|TotalVolume|Market
20110517|PHAR|705820|0|1733318|O
from http://regsho.finra.org/FORFshvol20110517.txt
http://regsho.finra.org/regsho-Index.html under ORF
Short Selling Data
Short Interest 4,942 (-75.17%)
Apr 29, 2011
Significant Failures to Deliver No
We will get an update of the FTDs soon and will know better if it is NSS
Do not forget: Short Sale Volume Reports are deceiving.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=63127600
GLTA
Vlad
GO PHAR
I think you need to read the post too
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=63225996
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=63226821
This only slightly better than a mailbox.
GLTA
Vlad
GO GDTK
Good find SloPoke, I called Bizhub and ask if they were still at the address and they said yes. I guess it is a little better than a UPS mailbox.
GLTA
Vlad
GO GDTK
Here is an image of the "crappy" building:
and here is a image of the "empty field" across the street.
mmmmm, I think this building looks pretty good and the "empty field" looks like a park, with basketball hoops and picnic tables. I would also say the office looks a lot better than the mailbox in the UPS store that so many pinks call their office.
Being that the language used to describe the building and the park were not too accurate maybe GDTK is not a POS either.
GLTA
Vlad
GO GDTK
Today's shorts 31%
Date|Symbol|ShortVolume|ShortExemptVolume|TotalVolume|Market
20110516|PHAR|208394|0|663232|O
from http://regsho.finra.org/FORFshvol20110516.txt
http://regsho.finra.org/regsho-Index.html under ORF
Short Selling Data
Short Interest 4,942 (-75.17%)
Apr 29, 2011
Significant Failures to Deliver No
We will get an update of the failures to deliver (FTD) tomorrow and will know better if it is NSS
Do not forget: Short Sale Volume Reportings are deceiving.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=63127600
GLTA
Vlad
GO PHAR
FINRA Short Sale Volume Reporting’s are deceiving.
What follows is not by me but an edited version of a commonly posted article. I do not know how much of this is true but I wanted to post it to show that the short numbers are not necessarily bad. GLTA Vlad GO PHAR
FINRA Short Sale Volume Reporting’s are deceiving.
Notice to Members memo dated 9/29/2009
http://www.finra.org/Industry/Regulation/Notices/2009/P120045
To maintain proper trade volume reporting accuracy, a trade with multiple legs in the trade would only be reported once in the volume reports. The example given would be.
Investor A is long 100 shares and wants to sell. They enter the order through their broker that is routed to a market maker. That market maker will go out and sell the stock into the market before they have bought the stock from you/your broker to close out their account. They do not take possession first as there is no guarantee they can sell the order into the market. By this Notice, the actual sale INTO the market is a short sale because the market maker sold the stock into the market BEFORE they had purchased the stock from you. It is a technicality since they know there position will be closed out minutes later when they go in and buy your shares. To avoid doubling up on trade volume and distorting the picture, only the sale into the market (consolidated tape) is recorded and not the second leg which was the sale transaction between seller and market maker.
So, this is why the short sale volume is high but also why the FTD’s and bi-Monthly short interest reports are not showing any indications of this volume. The short isn’t really a short it is the execution of a long sale by a market maker. The key language in the FINRA notice is this:
Quote:
--------------------------------------------------------------------------------
The Daily Short Sale Volume File will provide daily access to the aggregate volume of short sales
in NMS Stocks and OTC Equity Securities reported to a consolidated tape and traded over-the-counter
during regular trading hours on each trading day.
--------------------------------------------------------------------------------
Consolidated tape is the open market where the transaction between seller and market maker is not done at the consolidated tape. That call this the media transaction.
Now for those wondering about Bona-Fide Market Making, It can still be done but not electronically. The 15c-211 applies to electronic trade. Market Makers can continue to execute Bona-Fide Market making through phonic transactions but those sales made would be reported in the short interest reports bi-monthly and if not closed out will be reported as FTD’s in the system like any other trade failure.
Hope this helps at least clear up the high short interest volume reports seen. The reason the number is not 100% is because not all orders are routed thru independent market makers